Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation

LAUR Repository

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search LAUR

Advanced Search


My Account